Stevens Institute of Technology
6
4
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Role: collaborator
Nutrition for Precision Health, Powered by the All of Us
Role: collaborator
Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis
Role: collaborator
Cognitive-based Prosthetics to Improve Grasp and Reaching After SCI
Role: collaborator
Personalized Models for Cancer Research
Role: collaborator
Wearable Technology to Assess Gait Function in SMA and DMD
Role: collaborator
All 6 trials loaded